Edition:
United States

People: Abaxis Inc (ABAX.O)

ABAX.O on Nasdaq

50.84USD
27 Sep 2016
Change (% chg)

$0.27 (+0.53%)
Prev Close
$50.57
Open
$50.70
Day's High
$50.99
Day's Low
$50.26
Volume
81,823
Avg. Vol
143,688
52-wk High
$58.15
52-wk Low
$37.71

Aron, Kenneth 

Dr. Kenneth P. Aron, Ph.D., is Chief Technology Officer of the company. Dr. Aron joined us in February 2000 as Vice President of Research and Development. From April 1998 to November 1999, Dr. Aron was Vice President of Engineering and Technology of Incyte Pharmaceuticals (NASDAQ: INCY), a genomic information company. From April 1996 to April 1998, Dr. Aron was Vice President of Research, Development and Engineering for Cardiogenesis Corporation (NASDAQ: CGCP), a manufacturer of laser-based cardiology surgical products.

Basic Compensation

Total Annual Compensation, USD 999,419
Restricted Stock Awards, USD 1,347,060
Long-Term Incentive Plans, USD --
All Other, USD 27,322
Fiscal Year Total, USD 2,373,800

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Clinton Severson

3,948,450

Donald Wood

2,553,330

Ross Taylor

--

Kenneth Aron

2,373,800

Craig Tockman

--

Achim Henkel

2,044,750
As Of  30 Mar 2015